The Supreme Court, preemption, and malpractice liability.
نویسندگان
چکیده
559 Nonetheless, the extent to which gifts of food and other items will actually decrease will not be known for some time. Terms such as “occasional” and “modest” are open to interpretation. And the gifts of food and educational items that are still allowed could influence physicians’ behavior and benefit industry. It is also uncertain whether the provision of fewer gifts will lead to a decrease in overall spending on professional promotion or will merely shift spending to other sales and marketing activities.
منابع مشابه
The states, Congress, or the courts: who will be first to reform ERISA remedies?
Curtis Rooney's article reviews the ERISA law and it relationship to managed care. The piece continues with a review of the relevant preremption provisions and a extentivsive discussion of related U.S. Supreme Court decisions. The author discusses malpractice and design liabilities. The article concludes with a discussion of reform initiatives directed toward the ERISA preemption and damage pro...
متن کاملWill the Supreme Court finally eliminate ERISA preemption?
David Trueman's article reviews the history of ERISA preemption by analyzing seminal Supreme Court cases and predicts the future of ERISA preemption in his analysis of recent federal case law. Traditionally, the ability to hold a managed care entity responsible for its actions has been hampered by a strict interpretation of the preemption clauses of ERISA but as the Supreme Court's jurisprudenc...
متن کاملThe Transitioning Medical Professional Liability Market—Challenges in Valuing a Medical Professional Liability Company
Likely driven by continuing health reform efforts and the flight of physicians from administrative detail and operating risk, statistics indicate that the number of physicians in private practice has declined notably over the past 10 years. By the time the Affordable Care Act was upheld by the U.S. Supreme Court on June 28, 2012, at least one industry source was estimating that the number of ph...
متن کاملERISA update: the Supreme Court Texas decision and other recent developments.
This issue brief is part of a continuing series of policy papers published by The Robert Wood Johnson Foundation's State Coverage Initiatives program, housed at AcademyHealth, and the National Academy for State Health Policy on the state health policy implications of ERISA's preemption clause.1 The purpose of the brief is to explore the U.S. Supreme Court's June 2004 decision that ERISA preempt...
متن کاملThe impact of Wyeth v. Levine on FDA regulation of prescription drugs.
In Wyeth v. Levine, decided in March, 2009, the United States Supreme Court concluded that the plaintiff's failure to warn claim against the makers of the drug Phenergan was not impliedly preempted by the Food, Drug and Cosmetic Act. In doing so, the Court rejected the argument of the U.S. Food and Drug Administration (FDA) that tort claims of this nature stand as an obstacle to federal regulat...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- The New England journal of medicine
دوره 360 6 شماره
صفحات -
تاریخ انتشار 2009